Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 5Unspecified Adult Solid Tumor, Protocol Specific 3Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia 2Endometrial Neoplasms 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma, Extra-Adrenal 1Nonhematologic Malignancies 1Non-Squamous Non-Small Cell Lung Cancer 1Neoplastic Cells, Circulating 1Multiple Myeloma 1Mesothelioma, Malignant 1Meningeal Carcinomatosis 1Malignant Solid Tumour 1

Interventions

Radiotherapy 6Carboplatin 6Pemetrexed 5Cisplatin 5pembrolizumab 4Paclitaxel 4Docetaxel 4sargramostim 3Taxes 3Bevacizumab 32-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 3trametinib 2Radiotherapy, Conformal 2Platinum 2Etoposide 2Erlotinib Hydrochloride 2Cetuximab 2vandetanib 1tetrathiomolybdate 1spartalizumab 1sintilimab 1romidepsin 1ribociclib 1nazartinib 1naporafenib 1motexafin gadolinium 1motesanib diphosphate 1methoxyamine 1fludarabine phosphate 1canakinumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adenocarcinoma of Lung × Vinorelbine × Clear all
NCT00287963 2018-05-17

Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer

Medical University of South Carolina

Phase 1 Completed
18 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡